Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers project the Brazilian man could become the first person deemed cured of HIV without a bone marrow transplant.
Interfering with this receptor on immune cells could have harmful health consequences.
This alternative to Truvada for prevention among those at high risk of HIV warrants more advanced research to determine its efficacy.
“We need drugs that are gentler, kinder, better and cheaper.”
Selzentry (maraviroc) may emerge an alternative to Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP) against HIV.
What does the future hold for new pre-exposure prophylaxis (PrEP) against HIV, including long-acting injectables and less toxic drugs?
A weekly injection of an HIV antibody boasted a 98 percent success rate among participants in a small trial.
Levels of Selzentry (maraviroc) in vaginal and rectal tissues following a single dose were not high enough to be effective as PrEP in a recent...
An element of semen both lowers the effectiveness of many HIV microbicides and enhances the virus’s infectiousness, possibly explaining why re...
HIV-positive African Americans may not be able to maintain effective drug levels of Selzentry (maraviroc) at the antiretroviral’s standard dos...
In the future, women’s HIV prevention efforts may be as familiar a process as inserting a tampon, thanks to research showing that water-solubl...
Selzentry failed in a head-to-head with Truvada as a first-line treatment for HIV when each were paired with Prezista.
A majority of people taking antiretrovirals to treat HIV could switch to newer regimens with improved side effect profiles.
After many years of failures, recent studies have moved researchers closer to a form of HIV prevention that women can use discreetly.
He had a malfunctioning CCR5 receptor on his CD4 cells.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.